Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer
C Nisticò, C Garufi, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2005
Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?
G Ferretti, M Mandalà, E Bria, et al.
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
M Mottolese, M Benevolo, G Del Monte, et al.
Gut
|
May 13, 2005
Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?
G Ferretti, E Bria, P Carlini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer
C Garufi, F Lévi, A M Aschelter, et al.
Oncology
|
April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
Alessandra Fabi, G Metro, A Di Benedetto, et al.
American Journal of Clinical Oncology
|
April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study
V Ferraresi, M Milella, A Vaccaro, et al.
Anti-Cancer Drugs
|
September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
C Garufi, S Brienza, P Pugliese, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules
E Terzoli, C Nisticò, A Fabi, et al.
Breast Cancer Research and Treatment
|
October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women
M Milella, C Nisticò, V Ferraresi, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Phase II study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer
C Nisticò, C Garufi, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2005
Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?
G Ferretti, M Mandalà, E Bria, et al.
Journal of Cancer Research and Clinical Oncology
|
January 12, 2001
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy
M Mottolese, M Benevolo, G Del Monte, et al.
Gut
|
May 13, 2005
Is stool DNA multitarget testing an unreliable strategy for colorectal cancer screening?
G Ferretti, E Bria, P Carlini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 9, 1997
A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer
C Garufi, F Lévi, A M Aschelter, et al.
Oncology
|
April 15, 2010
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
Alessandra Fabi, G Metro, A Di Benedetto, et al.
American Journal of Clinical Oncology
|
April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II study
V Ferraresi, M Milella, A Vaccaro, et al.
Anti-Cancer Drugs
|
September 23, 2000
Overcoming resistance to chronomodulated 5-fluorouracil and folinic acid by the addition of chronomodulated oxaliplatin in advanced colorectal cancer patients
C Garufi, S Brienza, P Pugliese, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedules
E Terzoli, C Nisticò, A Fabi, et al.
Breast Cancer Research and Treatment
|
October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal women
M Milella, C Nisticò, V Ferraresi, et al.
Page
of 3